Sydney Jennings

Articles

Tirzepatide Superior to Semaglutide in Weight Loss Trial: Daily Dose

December 16, 2024

Your daily dose of the clinical news you may have missed.

Expert Perspectives 2024: The Dynamic Future of Obesity Medicine, with Donna Ryan, MD

December 16, 2024

The future of obesity medicine is filled with promise as GLP-1 RAs and other peptides continue to demonstrate pluripotency in metabolic disease.

FDA Review Sought for Lumateperone as Adjunctive Therapy for Major Depressive Disorder

December 13, 2024

Intra-Cellular Therapies submitted an sNDA to the FDA for lumateperone for the treatment of MDD in adults as as adjunctive therapy to antidepressants.

Role of Sleep in Dementia and Associated Comorbidities: Daily Dose

December 13, 2024

Your daily dose of the clinical news you may have missed.

Emerging Obesity Research to Watch For in 2025

December 12, 2024

Donna Ryan, MD, highlights exciting advancements in weight loss and metabolic treatments, particularly involving GLP-1 RAs and related therapies.

Antiobesity Drugs May Help Curb Alcohol Consumption: Daily Dose

December 12, 2024

Your daily dose of the clinical news you may have missed.

The Evolving Perception and Utilization of Antiobesity Drugs: Expert Discussion

December 11, 2024

Donna Ryan, MD, highlights how the media has helped to reframe obesity as a chronic disease and how antiobesity drugs are transforming metabolic disease treatment.

Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose

December 11, 2024

Your daily dose of the clinical news you may have missed.

Pivotal Obesity Trials in 2024: A Conversation with Donna Ryan, MD

December 10, 2024

Donna Ryan, MD, discusses the most significant clinical trials published this year in the field of obesity medicine.

Online UTI Myths Found Common, Dangerous: Daily Dose

December 10, 2024

Your daily dose of the clinical news you may have missed.